BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2187006)

  • 1. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
    Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
    Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
    Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
    Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
    Benarroch IS; Brodsky M; Rubinstein A; Viggiano C; Salama EA
    Ophthalmic Res; 1985; 17(3):131-8. PubMed ID: 4011126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P; Farine JC; Barras JP
    Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
    Salama Benarroch I; Nano H; Pérez H; Elizalde F; Bisceglia H; Salama A
    Ophthalmologica; 1977; 174(1):47-51. PubMed ID: 322009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
    Larsen HW; Sander E; Hoppe R
    Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.
    van Gerven JM; Boot JP; Lemkes HH; van Best JA
    Doc Ophthalmol; 1994; 87(4):355-65. PubMed ID: 7851219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of calcium dobesilate on blood hyperviscosity].
    Fortschr Med; 1979 Mar; 97(9):422. PubMed ID: 428880
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP; Michal M
    Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy.
    Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
    Diabetes; 1986 May; 35(5):574-8. PubMed ID: 3514333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclospasmol on early diabetic retinopathy.
    Mota MC; Leite E; Ruas MA; Verjans HL; Blakemore CB; Cunha-Vaz JG
    Int Ophthalmol; 1987 Feb; 10(1):3-9. PubMed ID: 3549595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5 years experimentation with calcium dobesilate in the treatment of retinopathies].
    Sévin R; Cuendet J-F
    Ophthalmologica; 1975; 170(2-3):232-8. PubMed ID: 1134739
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium dobesilate in the treatment of diabetic retinopathy.
    Garay RP; Hannaert P; Chiavaroli C
    Treat Endocrinol; 2005; 4(4):221-32. PubMed ID: 16053339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C; Koerner F
    Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy.
    Vinazzer H; Hachen HJ
    Vasa; 1987; 16(2):190-2. PubMed ID: 3300085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.